Wang Qi, Deng Jianping, Yuan Jun, Wang Liang, Zhao Zhenwei, He Shiming, . . . Tu Yanyang. (2012). Oncogenic reg IV is a novel prognostic marker for glioma patient survival. BMC.
Chicago Style (17th ed.) CitationWang Qi, Deng Jianping, Yuan Jun, Wang Liang, Zhao Zhenwei, He Shiming, Zhang Yongsheng, and Tu Yanyang. Oncogenic Reg IV Is a Novel Prognostic Marker for Glioma Patient Survival. BMC, 2012.
MLA (9th ed.) CitationWang Qi, et al. Oncogenic Reg IV Is a Novel Prognostic Marker for Glioma Patient Survival. BMC, 2012.
Warning: These citations may not always be 100% accurate.